Echocardiographic and renal changes in oncologic patients at risk of CTR-CVT treated with SGLT2 inhibitors: a paired 6-month follow-up analysis
20 June 2026 (08:30 - 18:00)
Organised by: 
Abstract
Slides
About the speaker
Heart and Brain Center of Excellence, Pleven (Bulgaria)
40 More presentations in this session
Absence of detectable cardiotoxicity with L-Annamycin despite high cumulative anthracycline exposure
Mr S. Waymack (Blacksburg, US)
Mr A. Alshahrani (Riyadh, SA)
Doctor M. Merhi (Berlin, DE)
Doctor M. Elelmi (Tunis, TN)
Doctor E. Bennour Ep Rabah (Tunis, TN)
Access the full session
The Event
ESC Cardio-Oncology 2026
20 June 2026
08:30 CET
You may be interested in
Congress Presentation
Congress Presentation
